))
How To Create Value And Why Pressure Is A Privilege With Ted Karkus CEO ProPhase Labs - $PRPH
Manage episode 412311108 series 3232962
内容由Adam Sarhan提供。所有播客内容（包括剧集、图形和播客描述）均由 Adam Sarhan 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Ted Karkus CEO & Chairman Of The Board Of ProPhase Labs $PRPH
Ticker: PRPH
Website:
Bio:
Ted Karkus
Chairman & CEO of ProPhase Labs
Ted Karkus, CEO and Chairman of ProPhase Labs, drives the company’s diverse and synergistic businesses with his successful track record in biomedical and health companies. He transformed ID Biomedical’s strategy and valuation from $25 million to $1.4 billion sale to GlaxoSmithKline. As CEO of ProPhase Labs, he restructured the go-to-market strategy for the flagship product Cold-EEZE, turned around and significantly grew revenues, ultimately selling it for $50 million to Mylan.
ProPhase Labs is a fast-growing biotech, genomics and diagnostics company due to its commitment to growth, innovation, and execution excellence outlined in Ted’s high growth roadmap. He pivoted into industry leading CLIA labs, and then further diversified by acquiring genomics leader Nebula Genomics. Constantly innovating, Ted then created ProPhase BioPharma to deliver antivirals, cancer tests and therapeutic cancer compounds. The new acquisitions and legacy businesses work to drive synergistic growth with multi-billion-dollar potential.
He holds a BS in Psychology from Tufts University with Magna Cum Laude Honors and an MBA in Finance from Columbia University School of Business with Beta Gamma Sigma Honors.
--- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support
176集单集
分享
